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skipping metastases.6,7 The clinical significance of
skipping metastases has to be clarified, and even the
definition of skipping metastasis itself has not yet been
generally agreed on. Meanwhile, it is hard to predict
from macroscopic appearances whether a lymph node is
involved or not. Large firm nodes are often free of dis-
ease, whereas small innocent-looking ones are dis-
eased. Until now, we have believed that complete dis-
section of mediastinal nodes is necessary for a curative
operation for lung cancer.
We reviewed the clinical records of patients with
completely resected non–small cell lung cancer to
assess the features and mode of mediastinal spread of
the tumor cells to lymph nodes. The purposes of this
study were to show the characteristics of skipping N2
lung cancer, to understand the significance of the cari-
nal node in dissecting mediastinal lymph nodes, and to
design a more effective and reasonable approach to
lymphadenectomy. This is a surgical series of patients
with lung cancer, all of whom had been subjected to
complete resections with complete nodal resection.
M etastasis to mediastinal lymph nodes, found inapproximately 20% to 40% of patients with
non–small cell lung cancer,1,2 is one of the most impor-
tant adverse factors for prognosis.3 Many physicians
believe surgery is not indicated when N2 disease is
found before thoracotomy, but some of these lesions
demonstrate a favorable prognosis after complete surgi-
cal resection.4,5 Although hilar lymph nodes are
anatomically positioned upstream from mediastinal
lymph nodes, metastases to mediastinal nodes without
metastases to hilar nodes are also seen and are called
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This mode of selection of patients influences the preva-
lence of nodal metastases, which will be lower than in
a series that includes all patients surgically treated for
lung cancer, as in our preliminary report.8 Now we pre-
sent the final results of our advanced study.
Patients and methods 
Of 956 consecutive patients who were operated on for pri-
mary lung cancer by the same surgical team from January
1986 through December 1996, 760 (79.5%) had non–small
cell carcinoma and were subjected to complete resection of
the tumor in combination with hilar and mediastinal lym-
phadenectomy. The patients’ ages ranged from 30 to 88 years
(mean 63 ± 9.6 years). The group included 568 men and 192
women. Whenever the parenchymal lesion was resectable, we
tried to remove all lymph nodes to render the patient tumor
free. Patients who had residual tumor at the resection margin
or evidence of malignant effusion were excluded. Tumors
with minute satellite nodules that were found incidentally
within the same lobe of the resected specimen were not
excluded from this study, because we were not certain
whether these lesions should be considered local tumor
spread. Tumors with satellite lesions in another lobe were
excluded. Resected specimens were examined histopatholog-
ically and histologic typing was done according to the World
Health Organization classification.9 Patients whose tumors
were subsequently classified as small cell carcinoma or low-
grade malignant tumor were also excluded. The stage of the
disease was determined on the basis of the criteria of the New
International Staging System for Lung Cancer,3 including
preoperative examinations, surgical findings, and pathologic
results of resected specimens. 
At operation, the lymph nodes of the ipsilateral thoracic
cavity were completely resected. We performed complete dis-
section of all the hilar and mediastinal nodes in every case.
Every node dissected en bloc (not sampled) was determined
by surgeons to be macroscopically positive or negative during
the operation and then examined by pathologists to be diag-
nosed as microscopically positive or negative after the opera-
tion. The sites of N2 lymph nodes were grouped as follows:
upper mediastinal (highest mediastinal nodes, paratracheal
nodes, pretracheal nodes, anterior mediastinal nodes, posteri-
or mediastinal nodes, and tracheobronchial angle nodes), aor-
tic (Botallo’s nodes, para-aortic nodes, and ascending aortic
nodes), and lower mediastinal (subcarinal nodes, parae-
sophageal nodes, and pulmonary ligament nodes) lymph
nodes. N1 nodes comprised hilar nodes (main bronchus
nodes, interlobar nodes, and lobar nodes).10,11 The results of
macroscopic evaluation were compared with those of the
pathologic examination. Mediastinal metastases were consid-
ered as so-called “skipping” metastases if any of the N2
nodes but no N1 nodes were involved. According to intraop-
erative appearance, metastatic lymph nodes were classified
into grossly positive or microscopic-only positive (so-called
false negative). Lymph nodes were immediately subjected to
pathologic examination of the frozen section. 
Patients were classified into the group bearing skipping
metastases and the group having non-skipping metastases.
The two groups were compared regarding several variables,
and the differences between them were evaluated by means of
the c 2 test.
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Table I. Profile of non–small cell carcinoma with complete resection and N2 dissection
Location of tumor
N factor RUL RML RLL LUL LLL Total
pN0 135 38 92 126 89 480
pN1 38 29 18 29 25 139
pN2 48 16 22 30 25 141
Total 221 93 132 185 139 760
RUL, Right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe.
Table II. Profile of patients with N2 lung cancer of
the so-called skipping and non-skipping groups
Skipping (+) Skipping (–) c 2
Characteristic (n = 53) (n = 88) P value
Age (y)
Mean 62 ± 9.1 62 ± 9.7
Range 41-77 33-78
Sex (male/female) 35/18 71/17 .05
Histology
Adenocarcinoma 42 56 .05




T1 14 17 .32
T2 29 38 .18
T3 8 16 .64
T4 2 17 .01
Lobe of tumor
Right upper 27 21 .001
Right middle 3 13 .10
Right lower 2 20 .002
Left upper 10 20 .59
Left lower 11 14 .47
Microscopic only 17/36 17/61 .19
positive/grossly positive
Results 
Lymph node involvement was recognized in 280
(36.8%) of the 760 patients evaluated: of the 280
patients, 139 patients (18.3%) had N1 node involve-
ment and 141 (18.6%) had N2 node involvement. The
relationship between the origin of the tumor and the
pathologic N factor is presented in Table I. Of the 141
patients with N2 involvement, 53 (37.6%) had skipping
metastases. Their clinical profiles are shown in Table
II. Although no statistically significant difference was
observed, the incidence of skipping metastases was
higher among women, patients with adenocarcinoma,
and patients with microscopic-only positive N2 nodes. 
Among 48 patients with N2 cancer of the right upper
lobe, 27 (56.3%) had skipping metastases involving the
upper mediastinal nodes but not the lower mediastinal
nodes. Of the 27 patients with skipping metastases, 9
(33.3%) were considered to have microscopic-only pos-
itive nodes. Among 30 patients with N2 cancer of the
left upper lobe, 10 (33.3%) had skipping metastases
involving the upper mediastinal or aortic lymph nodes
but not the lower mediastinal lymph nodes. Of the 41
patients with tumors in the right or left upper lobe and
non-skipping N2 metastases, that is, those who also
showed N1 involvement, 16 (39.0%) revealed subcari-
nal node involvement. Among 47 patients with N2 can-
cer of a lower lobe, 13 (27.7%) had skipping metastases
to mediastinal lymph nodes. Of these 13 patients, 11
(84.6%) had skipping metastases to the subcarinal
lymph node. Of the remaining 2 patients, 1 who had
microscopic-only positive skipping metastases to
Botallo’s nodes had bronchioloalveolar carcinoma, pul-
monary metastasis in the same lobe, and a tumor 80 mm
in diameter. The other patient, who had microscopic-
only positive skipping metastases to the paraesophageal
(below carina) nodes, had a tumor 70 mm in diameter. 
We investigated whether intraoperative misjudgment
of N1 lymph node involvement had greatly affected
selective dissection of N2 lymph nodes, because
metastatic involvement of N1 nodes might influence
the decision on the mode of lymphadenectomy for N2
nodes. Among 88 patients with non-skipping N2 can-
cer, 8 (9.7%) had microscopic-only positive N1 nodes,
which we mistook for negative nodes during the oper-
ation. Of the 5 patients with N2 cancer of an upper lobe
with microscopic-only positive N1 metastases, 4 had
metastases to the upper or aortic mediastinal lymph
nodes. The remaining patient, who had metastasis to
the subcarinal node, had a tumor 47 mm in diameter
and invasion of the pericardium. All 3 patients who had
N2 cancer of a lower lobe with microscopic-only posi-
tive N1 disease had metastases to the subcarinal node.
Discussion 
In the present study, so-called skipping metastases to
the mediastinal lymph nodes were recognized in
approximately 37% of the resected N2 cases. This rate
is close to those reported previously: 27% by Martini
and colleagues,1 28.6% by Ishida and colleagues,6 and
31.5% by Naruke.12 Positive nodes can be detected
because of their macroscopic appearance during the
operation in many instances. However, it is not rare to
macroscopically misjudge whether a lymph node is
involved. Therefore, if one has any doubt, the only
option is to completely resect the nodes. For that reason
complete dissection of the regional lymph nodes includ-
ing mediastinum is the standard procedure for patients
with lung cancer, even if no metastasis is observed in
the hilar lymph nodes at the time of thoracotomy.
However, the surgeon sometimes questions the wisdom
of performing such a dissection when all the nodes are
found to be negative in the postoperative pathologic
examination. Skipping metastases are of clinical signif-
icance because skipping spread occurs almost predomi-
nantly in cases of adenocarcinomas and the location of
skipping nodes is strongly affected by the origin of the
primary tumor. For example, in our series in patients
with tumors of an upper lobe, skipping involvement
occurred exclusively in the upper part of the medi-
astinum. Therefore such important nodes should not be
overlooked at the time of dissection or even for staging. 
We cannot explain the striking predominance of ade-
nocarcinoma among patients in whom only mediastinal
metastases were found. In this series, of the 53 patients
with skipping metastases, 42 (79.2%) had adenocarci-
noma. It is widely known that patients with adenocar-
cinoma have a poor prognosis, regardless of which
parameters describing the cancer are compared,13 and
our findings may explain this, at least in part. In addi-
tion, skipping metastases must be kept in mind even in
cases of squamous cell carcinoma, inasmuch as 11
patients (20.8%) had this cell type. 
One possible mechanism for the development of
skipping metastases may be the existence of lymphatic
channels going directly to the mediastinum. Riquet and
colleagues14 reported that subpleural lymphatics had
direct passages to the mediastinal lymph nodes in 22%
of the segments in the right lung and in 25% of the seg-
ments in the left lung. These investigators also stated
that those direct passages were observed more fre-
quently in the upper lobes,14 which might be one of the
reasons why skipping metastases from the upper lobes
occurred more frequently in this series. 
The location of the tumor influenced the extent of
nodal spread and the mode of nodal involvement. To
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compare the lymphatic routes with respect to site of the
primary tumor, we divided the mediastinum into upper
(including aortic) and lower regions. Metastatic spread
may occur beyond the regional mediastinum into the
nonregional mediastinum without involving lymph
nodes of the regional mediastinum. Concerning skip-
ping metastases from upper lobe lesions, in this series
all 37 patients exhibited metastases to the upper region
of the mediastinum, but none to the lower region. On
the other hand, only 1 of 13 patients (7.7%) with skip-
ping metastases from lower lobe lesions showed nodal
spread to the upper mediastinum only. Watanabe and
colleagues15 also reported that the frequency of skip-
ping metastases was only 22% from lower lobe lesions
to the upper part of the mediastinum and merely 8%
from upper lobe tumors to the lower part of the medi-
astinum. These results have something in common with
findings reported by Hata, Troidl, and Hasegawa.16
They demonstrated by lymphoscintigraphy that the
normal lymph drainage was through the regional medi-
astinum. From the lower lobe, only a small quantity of
dye reached the upper mediastinal lymph nodes. 
The question as to what extent of dissection should
be considered reasonable and acceptable has so far
attracted very little attention. In an attempt to answer it,
we investigated subcarinal node involvement by ana-
lyzing metastatic spread to nodes. Rouviere17 described
the subcarinal nodes as a crossroad where lymphatic
vessels from the various organs in the thorax meet
directly or by means of lymphoid relays, and commu-
nications are present between subcarinal nodes and all
lobes of the lungs. Nohl18 stated that in upper lobe can-
cers, subcarinal lymph node metastases usually oc-
curred as a result of involvement of nodes around the
main bronchus and noted that subcarinal involvement
was infrequent. Our data support these points. Among
patients with the so-called skipping N2 metastases with
an upper lobe lesion, none had positive subcarinal
nodes. In case of upper lobe tumors, lower mediastinal
nodes, including subcarinal nodes, were not involved if
the hilar and upper mediastinal nodes were free from
carcinoma cells. Therefore, in these cases, if the hilar
and upper mediastinal nodes, including aortic nodes,
were tumor-free, lower mediastinal lymphadenectomy
was dispensable. Only 1 of the patients with non-skip-
ping N2 metastases, an upper lobe lesion, and micro-
scopic-only positive N1 involvement on intraoperative
study had positive subcarinal nodes. A patient might be
expected to have positive subcarinal nodes before the
dissection was begun, based on the findings of pericar-
dial invasion. On the other hand, of patients with lower
lobe tumors showing both subcarinal and hilar negative
nodes, only 1 patient had positive nodes in the upper
part of the mediastinum; this patient had bronchi-
oloalveolar type and pulmonary metastases in the same
lobe. All of the patients with non-skipping N2 metas-
tases and a lower lobe tumor presenting macroscopic-
negative (microscopic-only positive) N1 metastases
intraoperatively had positive subcarinal nodes. For
these reasons, in these cases, upper mediastinal lym-
phadenectomy was dispensable when the hilar and sub-
carinal nodes were diagnosed to be tumor-free. We rec-
ommend an adequate use of frozen sections from key
nodes. As an exception, in patients with an advanced
stage of the disease based on findings such as extent of
invasion, complete hilar/mediastinal lymphadenectomy
should be routinely done so long as the patients are not
at a high risk and are thought to be able to tolerate this
surgical procedure. We therefore consider that the sub-
carinal node is of significance in defining skipping
metastases and should be excluded from the definition
of skip metastases to clarify its characteristics.
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